Use of sugars in cryopreserving human oocytes

Diane L. Wright, Ali Eroglu, Mehmet Toner, Thomas L. Toth

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

In the last 20 years, a worldwide effort to cryopreserve oocytes has resulted in 40 infants and approximately 50 ongoing pregnancies being reported. While the ability to freeze human embryos has become a standard of practice in assisted reproductive technologies, obtaining reliable techniques for oocyte cryopreservation has been more difficult. The unique properties of the mature oocyte, such as the meiotic stage with sensitive spindle structure as well as the large cell volume, are responsible for the limited success obtained to date. There have been two approaches to cryopreserving the oocyte: (i) slow freeze-rapid thaw, and (ii) vitrification protocols with rapid cooling-rapid warming. Both methods have incorporated sugars (sucrose) as a beneficial non-permeating extracellular cryoprotectant. Studies of organisms that survive extreme conditions of freezing/dehydration have demonstrated the ability to accumulate intracellular sugars to afford protection and survival. A novel technique using microinjection of sugars into the oocyte for cryopreservation has been developed as an alternative approach to external addition of sugars. Freezing the human oocyte has been a challenging goal; however, developing research and efforts will, in the near future, provide women with an important option for their reproductive health.

Original languageEnglish (US)
Pages (from-to)179-186
Number of pages8
JournalReproductive BioMedicine Online
Volume9
Issue number2
DOIs
StatePublished - Jan 1 2004

Fingerprint

Oocytes
Cryopreservation
Freezing
Vitrification
Assisted Reproductive Techniques
Reproductive Health
Microinjections
Cell Size
Dehydration
Sucrose
Embryonic Structures
Pregnancy
Survival
Research

Keywords

  • Birth
  • Human
  • Oocyte cryopreservation
  • Slow freezing
  • Sugar
  • Vitrification

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

Use of sugars in cryopreserving human oocytes. / Wright, Diane L.; Eroglu, Ali; Toner, Mehmet; Toth, Thomas L.

In: Reproductive BioMedicine Online, Vol. 9, No. 2, 01.01.2004, p. 179-186.

Research output: Contribution to journalArticle

Wright, Diane L. ; Eroglu, Ali ; Toner, Mehmet ; Toth, Thomas L. / Use of sugars in cryopreserving human oocytes. In: Reproductive BioMedicine Online. 2004 ; Vol. 9, No. 2. pp. 179-186.
@article{53d1a674aab34e08aeb1521435551695,
title = "Use of sugars in cryopreserving human oocytes",
abstract = "In the last 20 years, a worldwide effort to cryopreserve oocytes has resulted in 40 infants and approximately 50 ongoing pregnancies being reported. While the ability to freeze human embryos has become a standard of practice in assisted reproductive technologies, obtaining reliable techniques for oocyte cryopreservation has been more difficult. The unique properties of the mature oocyte, such as the meiotic stage with sensitive spindle structure as well as the large cell volume, are responsible for the limited success obtained to date. There have been two approaches to cryopreserving the oocyte: (i) slow freeze-rapid thaw, and (ii) vitrification protocols with rapid cooling-rapid warming. Both methods have incorporated sugars (sucrose) as a beneficial non-permeating extracellular cryoprotectant. Studies of organisms that survive extreme conditions of freezing/dehydration have demonstrated the ability to accumulate intracellular sugars to afford protection and survival. A novel technique using microinjection of sugars into the oocyte for cryopreservation has been developed as an alternative approach to external addition of sugars. Freezing the human oocyte has been a challenging goal; however, developing research and efforts will, in the near future, provide women with an important option for their reproductive health.",
keywords = "Birth, Human, Oocyte cryopreservation, Slow freezing, Sugar, Vitrification",
author = "Wright, {Diane L.} and Ali Eroglu and Mehmet Toner and Toth, {Thomas L.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S1472-6483(10)62127-X",
language = "English (US)",
volume = "9",
pages = "179--186",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Use of sugars in cryopreserving human oocytes

AU - Wright, Diane L.

AU - Eroglu, Ali

AU - Toner, Mehmet

AU - Toth, Thomas L.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - In the last 20 years, a worldwide effort to cryopreserve oocytes has resulted in 40 infants and approximately 50 ongoing pregnancies being reported. While the ability to freeze human embryos has become a standard of practice in assisted reproductive technologies, obtaining reliable techniques for oocyte cryopreservation has been more difficult. The unique properties of the mature oocyte, such as the meiotic stage with sensitive spindle structure as well as the large cell volume, are responsible for the limited success obtained to date. There have been two approaches to cryopreserving the oocyte: (i) slow freeze-rapid thaw, and (ii) vitrification protocols with rapid cooling-rapid warming. Both methods have incorporated sugars (sucrose) as a beneficial non-permeating extracellular cryoprotectant. Studies of organisms that survive extreme conditions of freezing/dehydration have demonstrated the ability to accumulate intracellular sugars to afford protection and survival. A novel technique using microinjection of sugars into the oocyte for cryopreservation has been developed as an alternative approach to external addition of sugars. Freezing the human oocyte has been a challenging goal; however, developing research and efforts will, in the near future, provide women with an important option for their reproductive health.

AB - In the last 20 years, a worldwide effort to cryopreserve oocytes has resulted in 40 infants and approximately 50 ongoing pregnancies being reported. While the ability to freeze human embryos has become a standard of practice in assisted reproductive technologies, obtaining reliable techniques for oocyte cryopreservation has been more difficult. The unique properties of the mature oocyte, such as the meiotic stage with sensitive spindle structure as well as the large cell volume, are responsible for the limited success obtained to date. There have been two approaches to cryopreserving the oocyte: (i) slow freeze-rapid thaw, and (ii) vitrification protocols with rapid cooling-rapid warming. Both methods have incorporated sugars (sucrose) as a beneficial non-permeating extracellular cryoprotectant. Studies of organisms that survive extreme conditions of freezing/dehydration have demonstrated the ability to accumulate intracellular sugars to afford protection and survival. A novel technique using microinjection of sugars into the oocyte for cryopreservation has been developed as an alternative approach to external addition of sugars. Freezing the human oocyte has been a challenging goal; however, developing research and efforts will, in the near future, provide women with an important option for their reproductive health.

KW - Birth

KW - Human

KW - Oocyte cryopreservation

KW - Slow freezing

KW - Sugar

KW - Vitrification

UR - http://www.scopus.com/inward/record.url?scp=4344604208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344604208&partnerID=8YFLogxK

U2 - 10.1016/S1472-6483(10)62127-X

DO - 10.1016/S1472-6483(10)62127-X

M3 - Article

C2 - 15333248

AN - SCOPUS:4344604208

VL - 9

SP - 179

EP - 186

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 2

ER -